×




Technology Commercialization at the Massachusetts General Hospital Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Technology Commercialization at the Massachusetts General Hospital case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Technology Commercialization at the Massachusetts General Hospital case study is a Harvard Business School (HBR) case study written by Jonathan West. The Technology Commercialization at the Massachusetts General Hospital (referred as “Csrl Commercialization” from here on) case study provides evaluation & decision scenario in field of Technology & Operations. It also touches upon business topics such as - Value proposition, Innovation, Intellectual property, Technology.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Technology Commercialization at the Massachusetts General Hospital Case Study


To maximize their effectiveness, color cases should be printed in color.The Department of Corporate Sponsored Research & Licensing (CSRL) at the Massachusetts General Hospital (MGH) serves as the primary interface between the hospital and the private sector. Examines the range of issues related to the commercialization of MGH's technologies. Discusses the debates surrounding the CSRL office mission and measures of its success as well as the impact of conflict of interest policies on technology development and commercialization.


Case Authors : Jonathan West

Topic : Technology & Operations

Related Areas : Innovation, Intellectual property, Technology




Calculating Net Present Value (NPV) at 6% for Technology Commercialization at the Massachusetts General Hospital Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10017378) -10017378 - -
Year 1 3455150 -6562228 3455150 0.9434 3259575
Year 2 3981635 -2580593 7436785 0.89 3543641
Year 3 3946284 1365691 11383069 0.8396 3313376
Year 4 3231768 4597459 14614837 0.7921 2559863
TOTAL 14614837 12676456




The Net Present Value at 6% discount rate is 2659078

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Payback Period
2. Internal Rate of Return
3. Profitability Index
4. Net Present Value

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Csrl Commercialization shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.
2. Timing of the expected cash flows – stockholders of Csrl Commercialization have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.






Formula and Steps to Calculate Net Present Value (NPV) of Technology Commercialization at the Massachusetts General Hospital

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Technology & Operations Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Csrl Commercialization often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Csrl Commercialization needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10017378) -10017378 - -
Year 1 3455150 -6562228 3455150 0.8696 3004478
Year 2 3981635 -2580593 7436785 0.7561 3010688
Year 3 3946284 1365691 11383069 0.6575 2594746
Year 4 3231768 4597459 14614837 0.5718 1847774
TOTAL 10457686


The Net NPV after 4 years is 440308

(10457686 - 10017378 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10017378) -10017378 - -
Year 1 3455150 -6562228 3455150 0.8333 2879292
Year 2 3981635 -2580593 7436785 0.6944 2765024
Year 3 3946284 1365691 11383069 0.5787 2283729
Year 4 3231768 4597459 14614837 0.4823 1558530
TOTAL 9486575


The Net NPV after 4 years is -530803

At 20% discount rate the NPV is negative (9486575 - 10017378 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Csrl Commercialization to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Csrl Commercialization has a NPV value higher than Zero then finance managers at Csrl Commercialization can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Csrl Commercialization, then the stock price of the Csrl Commercialization should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Csrl Commercialization should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What can impact the cash flow of the project.

What will be a multi year spillover effect of various taxation regulations.

Understanding of risks involved in the project.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Technology Commercialization at the Massachusetts General Hospital

References & Further Readings

Jonathan West (2018), "Technology Commercialization at the Massachusetts General Hospital Harvard Business Review Case Study. Published by HBR Publications.


Banca IFIS SWOT Analysis / TOWS Matrix

Financial , Consumer Financial Services


Jiangxi Selon Industrial SWOT Analysis / TOWS Matrix

Basic Materials , Chemical Manufacturing


La-Z-Boy SWOT Analysis / TOWS Matrix

Consumer Cyclical , Furniture & Fixtures


Nabriva Therapeutics SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Inovio SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Novocure Ltd SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Allied SWOT Analysis / TOWS Matrix

Financial , Consumer Financial Services


Encounter Technologi SWOT Analysis / TOWS Matrix

Technology , Software & Programming


Fortress Global SWOT Analysis / TOWS Matrix

Basic Materials , Paper & Paper Products